Search Results - "Grossman, Fred"

A randomized placebo-controlled trial of risperidone for the treatment of aggression, agitation, and psychosis of dementia by BRODATY, Henry, AMES, David, SNOWDON, John, WOODWARD, Michael, KIRWAN, Jeff, CLARNETTE, Roger, LEE, Emma, LYONS, Ben, GROSSMAN, Fred

“…This randomized, double-blind, placebo-controlled trial examined the efficacy and safety of risperidone in the treatment of aggression, agitation, and…”
Get full text

A Review of Anticonvulsants in Treating Agitated Demented Elderly Patients by Grossman, Fred

“…Agitation in the elderly, manifested by verbal and physical aggression, frequently results in increased morbidity and mortality for nursing home residents and…”
Get full text

GBR 830, an anti-OX40, improves skin gene signatures and clinical scores in patients with atopic dermatitis by Guttman-Yassky, Emma, Pavel, Ana B., Zhou, Lisa, Estrada, Yeriel D., Zhang, Ning, Xu, Hui, Peng, Xiangyu, Wen, Huei-Chi, Govas, Panayiota, Gudi, Girish, CA, Vinu, Fang, Hui, Salhi, Yacine, Back, Jonathan, Reddy, Venkateshwar, Bissonnette, Robert, Maari, Catherine, Grossman, Fred, Wolff, Gerhard

“…GBR 830 is a humanized mAb against OX40, a costimulatory receptor on activated T cells. OX40 inhibition might have a therapeutic role in T cell–mediated…”
Get full text

A Randomized Trial of Mesenchymal Stromal Cells for Moderate to Severe Acute Respiratory Distress Syndrome from COVID-19 by Bowdish, Michael E, Barkauskas, Christina E, Overbey, Jessica R, Gottlieb, Robert L, Osman, Keren, Duggal, Abhijit, Marks, Mary E, Hupf, Jonathan, Fernandes, Eustace, Leshnower, Bradley G, Golob, Jonathan L, Iribarne, Alexander, Rassias, Athos J, Moquete, Ellen G, O'Sullivan, Karen, Chang, Helena L, Williams, Judson B, Parnia, Sam, Patel, Nirav C, Desai, Nimesh D, Vekstein, Andrew M, Hollister, Beth A, Possemato, Tammie, Romero, Christian, Hou, Peter C, Burke, Elizabeth, Hayes, Jack, Grossman, Fred, Itescu, Silviu, Gillinov, Marc, Pagani, Francis D, O'Gara, Patrick T, Mack, Michael J, Smith, Peter K, Bagiella, Emilia, Moskowitz, Alan J, Gelijns, Annetine C

“…There are limited therapeutic options for patients with coronavirus disease (COVID-19)-related acute respiratory distress syndrome with inflammation-mediated…”
Get full text

184: Mesenchymal Stromal Cell Therapy for Acute Respiratory Distress Syndrome due to COVID-19 by Brown, Stacey-Ann Whittaker, Iancu-Rubin, Camelia, Aboelela, Adam, Abrahams, Alex, Burke, Elizabeth, Drummond, Tiffany, Grossman, Fred, Itescu, Silviu, Lagdameo, Jonathan, Lin, Jung-Yi, Mark, Alexis, Levine, John, Osman, Keren

Get full text

Mesenchymal stromal cell therapy induces high responses and survival in children with steroid refractory GVHD and poor risk biomarkers by Kasikis, Stelios, Baez, Janna, Gandhi, Isha, Grupp, Stephan, Kitko, Carrie L., Kowalyk, Steven, Merli, Pietro, Morales, George, Pulsipher, Michael A., Qayed, Muna, Wölfl, Matthias, Yanik, Gregory, See, Fiona, Hayes, Jack, Grossman, Fred, Burke, Elizabeth, Young, Rachel, Levine, John E., Ferrara, James L. M.

Get full text

Mesenchymal stromal cell therapy for acute respiratory distress syndrome due to coronavirus disease 2019 by Whittaker Brown, Stacey-Ann, Iancu-Rubin, Camelia, Aboelela, Adam, Abrahams, Alex, Burke, Elizabeth, Drummond, Tiffany, Grossman, Fred, Itescu, Silviu, Lagdameo, Jonathan, Lin, Jung-Yi, Mark, Alexis, Levine, John E., Osman, Keren

“…The acute respiratory distress syndrome (ARDS) resulting from coronavirus disease 2019 (COVID-19) is associated with a massive release of inflammatory…”
Get full text

Review of outcomes associated with restricted access to atypical antipsychotics by Rajagopalan, Krithika, Hassan, Marjam, Boswell, Kimberly, Sarnes, Evelyn, Meyer, Kellie, Grossman, Fred

“…Cost containment policies, such as prior authorization (PA), have increasingly been used by formulary decision makers to manage drug spending of the atypical…”
Get full text

Risperidone in the treatment of acute mania: Double-blind, placebo-controlled study by Khanna, Sumant, Vieta, Eduard, Lyons, Benjamin, Grossman, Fred, Eerdekens, Marielle, Kramer, Michelle

“…Severe mania is life-threatening, carries an increased risk of suicide and has a serious impact on patients and their families. Efficient and rapid control of…”
Get full text

Combination of a Mood Stabilizer With Risperidone or Haloperidol for Treatment of Acute Mania: A Double-Blind, Placebo-Controlled Comparison of Efficacy and Safety by Sachs, Gary S., Grossman, Fred, Ghaemi, S. Nassir, Okamoto, Akiko, Bowden, Charles L.

“…OBJECTIVE: The study assessed the efficacy and safety of risperidone as an adjunctive agent to mood stabilizers in the treatment of acute mania. METHOD: This…”
Get full text

Rapid Antimanic Effect of Risperidone Monotherapy: A 3-Week Multicenter, Double-Blind, Placebo-Controlled Trial by Hirschfeld, Robert M.A., Keck, Paul E., Kramer, Michelle, Karcher, Keith, Canuso, Carla, Eerdekens, Marielle, Grossman, Fred

“…OBJECTIVE: This study evaluated the efficacy and safety of risperidone monotherapy in the treatment of acute bipolar mania. METHOD: Patients with DSM-IV…”
Get full text

Mood stabilisers plus risperidone or placebo in the treatment of acute mania: International, double-blind, randomised controlled trial by YATHAM, LAKSAMI N, GROSSMAN, FRED, AUGUSTYNS, ILSE, VIETA, EDUARD, RAVINDRAN, ARUN

“…Few double-blind trials have examined the efficacy of a combination of a mood stabiliser and an atypical antipsychotic in acute mania. To determine the…”
Get full text

International multisite double-blind trial of the atypical antipsychotics risperidone and olanzapine in 175 elderly patients with chronic schizophrenia by Jeste, Dilip V, Barak, Yoram, Madhusoodanan, Subramoniam, Grossman, Fred, Gharabawi, Georges

“…The authors compared the effects of the two most commonly used atypical antipsychotics, risperidone and olanzapine, in elderly patients with schizophrenia. In…”
Get more information

Acute and continuation risperidone monotherapy in bipolar mania: a 3-week placebo-controlled trial followed by a 9-week double-blind trial of risperidone and haloperidol by Smulevich, Anatoly B., Khanna, Sumant, Eerdekens, Mariëlle, Karcher, Keith, Kramer, Michelle, Grossman, Fred

“…In a randomized, double-blind trial, patients with acute bipolar mania received 1–6 mg/day of risperidone, 2–12 mg/day of haloperidol, or placebo for 3 weeks,…”
Get full text

Cost-effectiveness of lurasidone vs aripiprazole among patients with schizophrenia who have previously failed on an atypical antipsychotic: an indirect comparison of outcomes from clinical trial data by Rajagopalan, Krithika, Hassan, Mariam, O'Day, Ken, Meyer, Kellie, Grossman, Fred

“…Compare long-term costs and outcomes of lurasidone to aripiprazole among adults with schizophrenia in the US who previously failed ≥1 atypical antipsychotic…”
Get more information

Percentage of WAIS-R standardization sample obtaining verbal-performance discrepancies by Grossman, Fred M

“…Computations were performed to determine the frequency in the standardization sample of specific Verbal-Performance discrepancies on the WAIS-R. All values…”
Get full text

Interpreting WISC-R Verbal-Performance Discrepancies: A Note for Practitioners by Grossman, Fred M.

“…Information relating to the significance of WISC-R Verbal-Performance IQ discrepancies and the frequencies of such differences in the standardization sample…”
Get full text

Risperidone in Combination with mood stabilizers: A 10-week continuation phase study in bipolar i disorder by BOWDEN, Charles L, MYERS, Joyce E, GROSSMAN, Fred, YANG XIE

“…Combination therapy (risperidone and a mood stabilizer) for patients with a history of bipolar disorder (DSM-IV) and hospitalized for treatment of a manic…”
Get full text

Risperidone in the Treatment of Elderly Patients with Psychosis of Alzheimer's Disease and Related Dementias by Grossman, Fred, Okamoto, Akiko, Turkoz, Ibrahim, Gharabawi, Georges

Get full text

Risperidone in the Treatment of Acute Mania: Double-Blind, Placebo-Controlled Study by Khanna, Sumant, Vieta, Eduard, Lyons, Benjamin, Grossman, Fred, Eerdekens, Marielle, Kramer, Michelle

“…Background. Severe mania is life-threatening, carries an increased risk of suicide and has a serious impact on patients and their families. Efficient and rapid…”
Get full text